輸入代號或公司名稱後按 Enter
4183

福永生技

-0.15 (-1.14%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
13.052成交張數本益比1.18股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率

營業收入2025500年增 +10.8%
毛利率202517.4%最新一期
營業利益率2025-1.8%最新一期
每股盈餘2025-0.33年增 -145.2%
會計項目走勢201720182019202020212022202320242025
銷貨收入+10.9%+4.0%+0.6%-3.5%+1.4%-4.1%+10.8%
銷貨收入淨額-1.3%+10.9%+4.0%+0.6%-3.5%+1.4%-4.1%+10.8%
營業收入合計-1.3%+10.9%+4.0%+0.6%-3.5%+1.4%-4.1%+10.8%
銷貨成本+0.1%+8.0%-0.3%+4.9%-1.0%-0.4%+0.1%+16.3%
營業成本合計+0.1%+8.0%-0.3%+4.9%-1.0%-0.4%+0.1%+16.3%
營業毛利(毛損)-5.8%+20.6%+16.7%-10.5%-11.0%+7.7%-16.8%-9.6%
營業毛利(毛損)淨額-5.8%+20.6%+16.7%-10.5%-11.0%+7.7%-16.8%-9.6%
推銷費用-13.5%-3.0%+6.2%-7.9%+7.0%-14.0%+17.6%+2.4%
管理費用+8.4%+4.6%+6.3%-8.2%+7.0%+4.7%-1.7%-1.7%
研究發展費用+4.6%+4.9%-8.0%+6.2%-4.3%+7.6%+0.6%+3.2%
預期信用減損損失(利益)-654.1%-6.5%+117.1%-94.0%
營業費用合計+2.0%+2.2%+3.3%-3.3%+4.3%-0.7%+0.1%+5.8%
營業利益(損失)-43.5%+181.8%+59.2%-25.1%-51.6%+55.6%-78.3%-268.5%
利息收入-82.5%+129.8%+6.9%-70.6%
其他收入+71.9%+8.7%-90.4%-41.6%+103.7%+105.9%-16.3%+27.2%
其他利益及損失淨額-146.3%-95.1%-99.7%
財務成本淨額-16.5%+354.5%-9.3%-4.7%-2.3%+0.0%-3.8%-7.7%
營業外收入及支出合計-146.7%-86.6%+706.1%-104.6%
稅前淨利(淨損)+235.6%+34.8%+66.9%-41.3%+16.7%-3.6%-32.7%-154.3%
所得稅費用(利益)合計-22.1%+177.1%+50.3%-41.7%-57.1%+160.8%-90.9%-461.3%
繼續營業單位本期淨利(淨損)+479.9%+16.7%+71.9%-41.2%+36.1%-17.2%-17.5%-145.4%
本期淨利(淨損)+479.9%+16.7%+71.9%-41.2%+36.1%-17.2%-17.5%-145.4%
確定福利計畫之再衡量數-19.0%-114.7%-10.5%+837.3%-95.0%-60.6%
與不重分類之項目相關之所得稅+114.3%-106.7%0.0%+772.7%-94.8%-501.6%
不重分類至損益之項目:-13.0%+855.0%-95.0%+48.8%
其他綜合損益(淨額)-45.7%-121.1%-13.0%+855.0%-95.0%+48.8%
本期綜合損益總額+473.3%+16.6%+72.2%-41.2%+37.8%-18.4%-16.4%-142.7%
基本每股盈餘+450.0%+16.7%+72.7%-41.4%+37.2%-17.8%-17.0%-145.2%
繼續營業單位淨利(淨損)+450.0%+16.7%+72.7%-41.4%+35.9%-17.0%-17.0%-145.2%
稀釋每股盈餘+450.0%+16.7%+72.7%-41.4%+35.9%-17.0%-17.0%-145.2%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。